401k Plan data: STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN plan

STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN 401k Plan overview

Plan Name	STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN
Plan identification number	001

STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Plan provides for automatic enrollment in plan that has employee contributions deducted from payroll.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.

401k Sponsoring company profile

STRATEGIC PHARMACEUTICAL SOLUTIONS DBA VETSOURCE has sponsored the creation of one or more 401k plans.

Company Name: STRATEGIC PHARMACEUTICAL SOLUTIONS DBA VETSOURCE

Employer identification number (EIN): 204318957

NAIC Classification: 325410

Additional information about STRATEGIC PHARMACEUTICAL SOLUTIONS DBA VETSOURCE

Jurisdiction of Incorporation: Oregon Secretary of State Corporations Division

Incorporation Date: 2005-12-05

Company Identification Number: 32659492

Legal Registered Office Address: 780 COMMERCIAL ST SE STE 100

SALEM
United States of America (USA)
97301

More information about STRATEGIC PHARMACEUTICAL SOLUTIONS DBA VETSOURCE

Form 5500 Filing Information

Submission information for form 5500 for 401k plan STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2022-01-01
001 2021-01-01
001 2020-01-01
001 2019-01-01
001 2018-01-01
001 2017-01-01 BECKY CURRIE
001 2017-01-01 EDWARD ROJAS
001 2017-01-01 EDWARD ROJAS
001 2016-01-01 BECKY CURRIE 2017-07-31
001 2015-01-01 REBECCA CURRIE 2016-05-10
001 2014-01-01 BECKY CURRIE 2015-05-26
001 2013-01-01 KURT GREEN 2014-06-12
001 2012-01-01 STRATEGIC PHARMACEUTICAL SOLUT
001 2011-01-01 KURT GREEN 2012-04-04 KURT GREEN 2012-04-04
001 2010-01-01 REBECCA CURRIE 2011-03-22 REBECCA CURRIE 2011-07-18

Plan id#	Filing Submission Date	Name of Administrator	Date Administrator Signed	Name of Company Sponsor	Date Sponsor Signed
001	2022-01-01
001	2021-01-01
001	2020-01-01
001	2019-01-01
001	2018-01-01
001	2017-01-01	BECKY CURRIE
001	2017-01-01	EDWARD ROJAS
001	2017-01-01	EDWARD ROJAS
001	2016-01-01	BECKY CURRIE	2017-07-31
001	2015-01-01	REBECCA CURRIE	2016-05-10
001	2014-01-01	BECKY CURRIE	2015-05-26
001	2013-01-01	KURT GREEN	2014-06-12
001	2012-01-01	STRATEGIC PHARMACEUTICAL SOLUT
001	2011-01-01	KURT GREEN	2012-04-04	KURT GREEN	2012-04-04
001	2010-01-01	REBECCA CURRIE	2011-03-22	REBECCA CURRIE	2011-07-18

Plan Statistics for STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN

401k plan membership statisitcs for STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN

Measure Date Value
2022: STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN 2022 401k membership
Total participants, beginning-of-year 2022-01-01 557
Total number of active participants reported on line 7a of the Form 5500 2022-01-01 585
Number of retired or separated participants receiving benefits 2022-01-01 0
Number of other retired or separated participants entitled to future benefits 2022-01-01 77
Total of all active and inactive participants 2022-01-01 662
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2022-01-01 0
Total participants 2022-01-01 662
Number of participants with account balances 2022-01-01 655
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2022-01-01 28
2021: STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN 2021 401k membership
Total participants, beginning-of-year 2021-01-01 402
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 491
Number of retired or separated participants receiving benefits 2021-01-01 0
Number of other retired or separated participants entitled to future benefits 2021-01-01 51
Total of all active and inactive participants 2021-01-01 542
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 0
Total participants 2021-01-01 542
Number of participants with account balances 2021-01-01 517
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2021-01-01 30
2020: STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN 2020 401k membership
Total participants, beginning-of-year 2020-01-01 351
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 350
Number of retired or separated participants receiving benefits 2020-01-01 0
Number of other retired or separated participants entitled to future benefits 2020-01-01 37
Total of all active and inactive participants 2020-01-01 387
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 0
Total participants 2020-01-01 387
Number of participants with account balances 2020-01-01 384
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 35
2019: STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN 2019 401k membership
Total participants, beginning-of-year 2019-01-01 326
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 309
Number of retired or separated participants receiving benefits 2019-01-01 0
Number of other retired or separated participants entitled to future benefits 2019-01-01 31
Total of all active and inactive participants 2019-01-01 340
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 0
Total participants 2019-01-01 340
Number of participants with account balances 2019-01-01 339
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 14
2018: STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN 2018 401k membership
Total participants, beginning-of-year 2018-01-01 211
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 299
Number of retired or separated participants receiving benefits 2018-01-01 0
Number of other retired or separated participants entitled to future benefits 2018-01-01 27
Total of all active and inactive participants 2018-01-01 326
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 0
Total participants 2018-01-01 326
Number of participants with account balances 2018-01-01 315
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 0
2017: STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN 2017 401k membership
Total participants, beginning-of-year 2017-01-01 166
Total number of active participants reported on line 7a of the Form 5500 2017-01-01 200
Number of retired or separated participants receiving benefits 2017-01-01 0
Number of other retired or separated participants entitled to future benefits 2017-01-01 14
Total of all active and inactive participants 2017-01-01 214
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-01-01 0
Total participants 2017-01-01 214
Number of participants with account balances 2017-01-01 93
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-01-01 0
2012: STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN 2012 401k membership
Total participants, beginning-of-year 2012-01-01 69
Total number of active participants reported on line 7a of the Form 5500 2012-01-01 72
Number of retired or separated participants receiving benefits 2012-01-01 0
Number of other retired or separated participants entitled to future benefits 2012-01-01 4
Total of all active and inactive participants 2012-01-01 76
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2012-01-01 0
Total participants 2012-01-01 76
Number of participants with account balances 2012-01-01 41
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2012-01-01 0

Measure	Date	Value
2022: STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN 2022 401k membership
Total participants, beginning-of-year	2022-01-01	557
Total number of active participants reported on line 7a of the Form 5500	2022-01-01	585
Number of retired or separated participants receiving benefits	2022-01-01	0
Number of other retired or separated participants entitled to future benefits	2022-01-01	77
Total of all active and inactive participants	2022-01-01	662
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2022-01-01	0
Total participants	2022-01-01	662
Number of participants with account balances	2022-01-01	655
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2022-01-01	28
2021: STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN 2021 401k membership
Total participants, beginning-of-year	2021-01-01	402
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	491
Number of retired or separated participants receiving benefits	2021-01-01	0
Number of other retired or separated participants entitled to future benefits	2021-01-01	51
Total of all active and inactive participants	2021-01-01	542
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	0
Total participants	2021-01-01	542
Number of participants with account balances	2021-01-01	517
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2021-01-01	30
2020: STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN 2020 401k membership
Total participants, beginning-of-year	2020-01-01	351
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	350
Number of retired or separated participants receiving benefits	2020-01-01	0
Number of other retired or separated participants entitled to future benefits	2020-01-01	37
Total of all active and inactive participants	2020-01-01	387
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	0
Total participants	2020-01-01	387
Number of participants with account balances	2020-01-01	384
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	35
2019: STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN 2019 401k membership
Total participants, beginning-of-year	2019-01-01	326
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	309
Number of retired or separated participants receiving benefits	2019-01-01	0
Number of other retired or separated participants entitled to future benefits	2019-01-01	31
Total of all active and inactive participants	2019-01-01	340
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	0
Total participants	2019-01-01	340
Number of participants with account balances	2019-01-01	339
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	14
2018: STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN 2018 401k membership
Total participants, beginning-of-year	2018-01-01	211
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	299
Number of retired or separated participants receiving benefits	2018-01-01	0
Number of other retired or separated participants entitled to future benefits	2018-01-01	27
Total of all active and inactive participants	2018-01-01	326
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	0
Total participants	2018-01-01	326
Number of participants with account balances	2018-01-01	315
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	0
2017: STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN 2017 401k membership
Total participants, beginning-of-year	2017-01-01	166
Total number of active participants reported on line 7a of the Form 5500	2017-01-01	200
Number of retired or separated participants receiving benefits	2017-01-01	0
Number of other retired or separated participants entitled to future benefits	2017-01-01	14
Total of all active and inactive participants	2017-01-01	214
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-01-01	0
Total participants	2017-01-01	214
Number of participants with account balances	2017-01-01	93
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-01-01	0
2012: STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN 2012 401k membership
Total participants, beginning-of-year	2012-01-01	69
Total number of active participants reported on line 7a of the Form 5500	2012-01-01	72
Number of retired or separated participants receiving benefits	2012-01-01	0
Number of other retired or separated participants entitled to future benefits	2012-01-01	4
Total of all active and inactive participants	2012-01-01	76
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2012-01-01	0
Total participants	2012-01-01	76
Number of participants with account balances	2012-01-01	41
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2012-01-01	0

Financial Data on STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN

Measure	Date	Value
2022 : STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN 2022 401k financial data
Total unrealized appreciation/depreciation of assets	2022-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$0
Total income from all sources (including contributions)	2022-12-31	$3,342,829
Total loss/gain on sale of assets	2022-12-31	$0
Total of all expenses incurred	2022-12-31	$1,381,879
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2022-12-31	$1,285,739
Value of total corrective distributions	2022-12-31	$539
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2022-12-31	$6,062,629
Value of total assets at end of year	2022-12-31	$16,222,988
Value of total assets at beginning of year	2022-12-31	$14,262,038
Total of administrative expenses incurred including professional, contract, advisory and management fees	2022-12-31	$95,601
Total interest from all sources	2022-12-31	$10,667
Total dividends received (eg from common stock, registered investment company shares)	2022-12-31	$45,260
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2022-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2022-12-31	$45,260
Was this plan covered by a fidelity bond	2022-12-31	Yes
Value of fidelity bond cover	2022-12-31	$10,000,000
If this is an individual account plan, was there a blackout period	2022-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2022-12-31	No
Contributions received from participants	2022-12-31	$3,103,304
Participant contributions at end of year	2022-12-31	$261,652
Participant contributions at beginning of year	2022-12-31	$190,234
Participant contributions at end of year	2022-12-31	$110,677
Participant contributions at beginning of year	2022-12-31	$91,489
Income. Received or receivable in cash from other sources (including rollovers)	2022-12-31	$1,436,301
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2022-12-31	$783
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Value of net income/loss	2022-12-31	$1,960,950
Value of net assets at end of year (total assets less liabilities)	2022-12-31	$16,222,988
Value of net assets at beginning of year (total assets less liabilities)	2022-12-31	$14,262,038
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2022-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2022-12-31	No
Were any leases to which the plan was party in default or uncollectible	2022-12-31	No
Investment advisory and management fees	2022-12-31	$35,698
Value of interest in registered invesment companies (eg mutual funds) at end of year	2022-12-31	$3,397,825
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2022-12-31	$2,853,701
Value of interest in pooled separate accounts at end of year	2022-12-31	$298,814
Value of interest in pooled separate accounts at beginning of year	2022-12-31	$183,479
Interest on participant loans	2022-12-31	$10,667
Value of interest in common/collective trusts at end of year	2022-12-31	$12,095,135
Value of interest in common/collective trusts at beginning of year	2022-12-31	$10,903,377
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2022-12-31	$-731,836
Net investment gain/loss from pooled separate accounts	2022-12-31	$-56,111
Net investment gain or loss from common/collective trusts	2022-12-31	$-1,987,780
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2022-12-31	No
Was there a failure to transmit to the plan any participant contributions	2022-12-31	No
Has the plan failed to provide any benefit when due under the plan	2022-12-31	No
Contributions received in cash from employer	2022-12-31	$1,523,024
Employer contributions (assets) at end of year	2022-12-31	$58,885
Employer contributions (assets) at beginning of year	2022-12-31	$39,758
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2022-12-31	$1,284,956
Contract administrator fees	2022-12-31	$59,903
Did the plan have assets held for investment	2022-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2022-12-31	No
Opinion of an independent qualified public accountant for this plan	2022-12-31	Unqualified
Accountancy firm name	2022-12-31	ALDRICH CPA'S AND ADVISORS LLP
Accountancy firm EIN	2022-12-31	930623286
2021 : STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN 2021 401k financial data
Total unrealized appreciation/depreciation of assets	2021-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total income from all sources (including contributions)	2021-12-31	$6,365,135
Total loss/gain on sale of assets	2021-12-31	$0
Total of all expenses incurred	2021-12-31	$1,467,847
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-12-31	$1,382,596
Expenses. Certain deemed distributions of participant loans	2021-12-31	$871
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-12-31	$4,727,030
Value of total assets at end of year	2021-12-31	$14,262,038
Value of total assets at beginning of year	2021-12-31	$9,364,750
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-12-31	$84,380
Total interest from all sources	2021-12-31	$8,593
Total dividends received (eg from common stock, registered investment company shares)	2021-12-31	$23,826
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2021-12-31	$23,826
Was this plan covered by a fidelity bond	2021-12-31	Yes
Value of fidelity bond cover	2021-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2021-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2021-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2021-12-31	No
Contributions received from participants	2021-12-31	$2,321,832
Participant contributions at end of year	2021-12-31	$190,234
Participant contributions at beginning of year	2021-12-31	$111,255
Participant contributions at end of year	2021-12-31	$91,489
Participant contributions at beginning of year	2021-12-31	$55,122
Income. Received or receivable in cash from other sources (including rollovers)	2021-12-31	$1,468,853
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Value of net income/loss	2021-12-31	$4,897,288
Value of net assets at end of year (total assets less liabilities)	2021-12-31	$14,262,038
Value of net assets at beginning of year (total assets less liabilities)	2021-12-31	$9,364,750
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-12-31	No
Were any leases to which the plan was party in default or uncollectible	2021-12-31	No
Investment advisory and management fees	2021-12-31	$35,539
Value of interest in registered invesment companies (eg mutual funds) at end of year	2021-12-31	$2,853,701
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2021-12-31	$1,476,382
Value of interest in pooled separate accounts at end of year	2021-12-31	$183,479
Value of interest in pooled separate accounts at beginning of year	2021-12-31	$166,385
Interest on participant loans	2021-12-31	$8,593
Value of interest in common/collective trusts at end of year	2021-12-31	$10,903,377
Value of interest in common/collective trusts at beginning of year	2021-12-31	$7,530,782
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2021-12-31	$289,631
Net investment gain/loss from pooled separate accounts	2021-12-31	$13,641
Net investment gain or loss from common/collective trusts	2021-12-31	$1,302,414
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-12-31	No
Was there a failure to transmit to the plan any participant contributions	2021-12-31	No
Has the plan failed to provide any benefit when due under the plan	2021-12-31	No
Contributions received in cash from employer	2021-12-31	$936,345
Employer contributions (assets) at end of year	2021-12-31	$39,758
Employer contributions (assets) at beginning of year	2021-12-31	$24,824
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-12-31	$1,382,596
Contract administrator fees	2021-12-31	$48,841
Did the plan have assets held for investment	2021-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-12-31	No
Opinion of an independent qualified public accountant for this plan	2021-12-31	Unqualified
Accountancy firm name	2021-12-31	ALDRICH CPA'S AND ADVISORS LLP
Accountancy firm EIN	2021-12-31	930623286
2020 : STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN 2020 401k financial data
Unrealized appreciation/depreciation of real estate assets	2020-12-31	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2020-12-31	$0
Total unrealized appreciation/depreciation of assets	2020-12-31	$0
Total transfer of assets to this plan	2020-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total income from all sources (including contributions)	2020-12-31	$3,996,621
Total loss/gain on sale of assets	2020-12-31	$0
Total of all expenses incurred	2020-12-31	$1,139,821
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-12-31	$1,080,165
Expenses. Certain deemed distributions of participant loans	2020-12-31	$0
Value of total corrective distributions	2020-12-31	$1,134
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-12-31	$2,646,404
Value of total assets at end of year	2020-12-31	$9,364,750
Value of total assets at beginning of year	2020-12-31	$6,507,950
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-12-31	$58,522
Total income from rents	2020-12-31	$0
Total interest from all sources	2020-12-31	$5,684
Total dividends received (eg from common stock, registered investment company shares)	2020-12-31	$13,686
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2020-12-31	$13,686
Administrative expenses professional fees incurred	2020-12-31	$0
Was this plan covered by a fidelity bond	2020-12-31	Yes
Value of fidelity bond cover	2020-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2020-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2020-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2020-12-31	No
Amount of non-exempt transactions with any party-in-interest	2020-12-31	$0
Contributions received from participants	2020-12-31	$1,671,202
Participant contributions at end of year	2020-12-31	$111,255
Participant contributions at beginning of year	2020-12-31	$74,482
Participant contributions at end of year	2020-12-31	$55,122
Participant contributions at beginning of year	2020-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2020-12-31	$262,189
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2020-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at end of year	2020-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2020-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2020-12-31	$0
Other income not declared elsewhere	2020-12-31	$132
Administrative expenses (other) incurred	2020-12-31	$0
Liabilities. Value of operating payables at beginning of year	2020-12-31	$0
Total non interest bearing cash at end of year	2020-12-31	$0
Total non interest bearing cash at beginning of year	2020-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Value of net income/loss	2020-12-31	$2,856,800
Value of net assets at end of year (total assets less liabilities)	2020-12-31	$9,364,750
Value of net assets at beginning of year (total assets less liabilities)	2020-12-31	$6,507,950
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-12-31	No
Amount of loans by the plan or fixed income obligations due to the plan which were in default/classified-as-uncollectible as of the close of the plan year	2020-12-31	$0
Were any leases to which the plan was party in default or uncollectible	2020-12-31	No
Amount of leases to which the plan was a party which were in default/classified-as-uncollectible during the year	2020-12-31	$0
Investment advisory and management fees	2020-12-31	$22,944
Value of interest in registered invesment companies (eg mutual funds) at end of year	2020-12-31	$1,476,382
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2020-12-31	$966,602
Value of interest in pooled separate accounts at end of year	2020-12-31	$166,385
Value of interest in pooled separate accounts at beginning of year	2020-12-31	$118,501
Interest on participant loans	2020-12-31	$5,684
Income. Interest from loans (other than to participants)	2020-12-31	$0
Interest earned on other investments	2020-12-31	$0
Income. Interest from US Government securities	2020-12-31	$0
Income. Interest from corporate debt instruments	2020-12-31	$0
Value of interest in common/collective trusts at end of year	2020-12-31	$7,530,782
Value of interest in common/collective trusts at beginning of year	2020-12-31	$5,348,365
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2020-12-31	$0
Expenses. Payments to insurance carriers foe the provision of benefits	2020-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2020-12-31	$281,313
Net investment gain/loss from pooled separate accounts	2020-12-31	$37,847
Net investment gain or loss from common/collective trusts	2020-12-31	$1,011,555
Net gain/loss from 103.12 investment entities	2020-12-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-12-31	No
Was there a failure to transmit to the plan any participant contributions	2020-12-31	No
Has the plan failed to provide any benefit when due under the plan	2020-12-31	No
Contributions received in cash from employer	2020-12-31	$713,013
Employer contributions (assets) at end of year	2020-12-31	$24,824
Employer contributions (assets) at beginning of year	2020-12-31	$0
Income. Dividends from preferred stock	2020-12-31	$0
Income. Dividends from common stock	2020-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-12-31	$1,080,165
Contract administrator fees	2020-12-31	$35,578
Liabilities. Value of benefit claims payable at beginning of year	2020-12-31	$0
Did the plan have assets held for investment	2020-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-12-31	No
Aggregate proceeds on sale of assets	2020-12-31	$0
Aggregate carrying amount (costs) on sale of assets	2020-12-31	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2020-12-31	$0
Opinion of an independent qualified public accountant for this plan	2020-12-31	Unqualified
Accountancy firm name	2020-12-31	ALDRICH CPA'S AND ADVISORS LLP
Accountancy firm EIN	2020-12-31	930623286
2019 : STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN 2019 401k financial data
Unrealized appreciation/depreciation of real estate assets	2019-12-31	$0
Unrealized appreciation/depreciation of real estate assets	2019-12-31	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2019-12-31	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2019-12-31	$0
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total transfer of assets to this plan	2019-12-31	$0
Total transfer of assets to this plan	2019-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total income from all sources (including contributions)	2019-12-31	$3,369,182
Total income from all sources (including contributions)	2019-12-31	$3,369,182
Total loss/gain on sale of assets	2019-12-31	$0
Total loss/gain on sale of assets	2019-12-31	$0
Total of all expenses incurred	2019-12-31	$481,653
Total of all expenses incurred	2019-12-31	$481,653
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$431,203
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$431,203
Expenses. Certain deemed distributions of participant loans	2019-12-31	$0
Expenses. Certain deemed distributions of participant loans	2019-12-31	$0
Value of total corrective distributions	2019-12-31	$6,741
Value of total corrective distributions	2019-12-31	$6,741
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$2,367,635
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$2,367,635
Value of total assets at end of year	2019-12-31	$6,507,950
Value of total assets at beginning of year	2019-12-31	$3,620,421
Value of total assets at beginning of year	2019-12-31	$3,620,421
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$43,709
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$43,709
Total income from rents	2019-12-31	$0
Total income from rents	2019-12-31	$0
Total interest from all sources	2019-12-31	$4,740
Total interest from all sources	2019-12-31	$4,740
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$13,189
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$13,189
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$13,189
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$13,189
Administrative expenses professional fees incurred	2019-12-31	$0
Administrative expenses professional fees incurred	2019-12-31	$0
Was this plan covered by a fidelity bond	2019-12-31	Yes
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$1,000,000
Value of fidelity bond cover	2019-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2019-12-31	No
If this is an individual account plan, was there a blackout period	2019-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2019-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Amount of non-exempt transactions with any party-in-interest	2019-12-31	$0
Amount of non-exempt transactions with any party-in-interest	2019-12-31	$0
Contributions received from participants	2019-12-31	$1,392,638
Contributions received from participants	2019-12-31	$1,392,638
Participant contributions at end of year	2019-12-31	$74,482
Participant contributions at end of year	2019-12-31	$74,482
Participant contributions at beginning of year	2019-12-31	$79,424
Participant contributions at beginning of year	2019-12-31	$79,424
Participant contributions at end of year	2019-12-31	$0
Participant contributions at end of year	2019-12-31	$0
Participant contributions at beginning of year	2019-12-31	$0
Participant contributions at beginning of year	2019-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$378,483
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$378,483
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2019-12-31	$78
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2019-12-31	$78
Value of other receiveables (less allowance for doubtful accounts) at end of year	2019-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at end of year	2019-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2019-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2019-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2019-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2019-12-31	$0
Other income not declared elsewhere	2019-12-31	$1,254
Other income not declared elsewhere	2019-12-31	$1,254
Administrative expenses (other) incurred	2019-12-31	$0
Administrative expenses (other) incurred	2019-12-31	$0
Liabilities. Value of operating payables at beginning of year	2019-12-31	$0
Liabilities. Value of operating payables at beginning of year	2019-12-31	$0
Total non interest bearing cash at end of year	2019-12-31	$0
Total non interest bearing cash at end of year	2019-12-31	$0
Total non interest bearing cash at beginning of year	2019-12-31	$0
Total non interest bearing cash at beginning of year	2019-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Value of net income/loss	2019-12-31	$2,887,529
Value of net income/loss	2019-12-31	$2,887,529
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$6,507,950
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$6,507,950
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$3,620,421
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$3,620,421
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Amount of loans by the plan or fixed income obligations due to the plan which were in default/classified-as-uncollectible as of the close of the plan year	2019-12-31	$0
Amount of loans by the plan or fixed income obligations due to the plan which were in default/classified-as-uncollectible as of the close of the plan year	2019-12-31	$0
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Amount of leases to which the plan was a party which were in default/classified-as-uncollectible during the year	2019-12-31	$0
Investment advisory and management fees	2019-12-31	$16,409
Investment advisory and management fees	2019-12-31	$16,409
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$966,602
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$966,602
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$546,244
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$546,244
Value of interest in pooled separate accounts at end of year	2019-12-31	$118,501
Value of interest in pooled separate accounts at end of year	2019-12-31	$118,501
Value of interest in pooled separate accounts at beginning of year	2019-12-31	$67,016
Value of interest in pooled separate accounts at beginning of year	2019-12-31	$67,016
Interest on participant loans	2019-12-31	$4,740
Interest on participant loans	2019-12-31	$4,740
Income. Interest from loans (other than to participants)	2019-12-31	$0
Income. Interest from loans (other than to participants)	2019-12-31	$0
Interest earned on other investments	2019-12-31	$0
Interest earned on other investments	2019-12-31	$0
Income. Interest from US Government securities	2019-12-31	$0
Income. Interest from US Government securities	2019-12-31	$0
Income. Interest from corporate debt instruments	2019-12-31	$0
Income. Interest from corporate debt instruments	2019-12-31	$0
Value of interest in common/collective trusts at end of year	2019-12-31	$5,348,365
Value of interest in common/collective trusts at end of year	2019-12-31	$5,348,365
Value of interest in common/collective trusts at beginning of year	2019-12-31	$2,927,737
Value of interest in common/collective trusts at beginning of year	2019-12-31	$2,927,737
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2019-12-31	$0
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2019-12-31	$0
Expenses. Payments to insurance carriers foe the provision of benefits	2019-12-31	$0
Expenses. Payments to insurance carriers foe the provision of benefits	2019-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$160,007
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$160,007
Net investment gain/loss from pooled separate accounts	2019-12-31	$22,704
Net investment gain/loss from pooled separate accounts	2019-12-31	$22,704
Net investment gain or loss from common/collective trusts	2019-12-31	$799,653
Net investment gain or loss from common/collective trusts	2019-12-31	$799,653
Net gain/loss from 103.12 investment entities	2019-12-31	$0
Net gain/loss from 103.12 investment entities	2019-12-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Contributions received in cash from employer	2019-12-31	$596,514
Contributions received in cash from employer	2019-12-31	$596,514
Employer contributions (assets) at end of year	2019-12-31	$0
Employer contributions (assets) at end of year	2019-12-31	$0
Employer contributions (assets) at beginning of year	2019-12-31	$0
Employer contributions (assets) at beginning of year	2019-12-31	$0
Income. Dividends from preferred stock	2019-12-31	$0
Income. Dividends from preferred stock	2019-12-31	$0
Income. Dividends from common stock	2019-12-31	$0
Income. Dividends from common stock	2019-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$431,125
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$431,125
Contract administrator fees	2019-12-31	$27,300
Contract administrator fees	2019-12-31	$27,300
Liabilities. Value of benefit claims payable at beginning of year	2019-12-31	$0
Liabilities. Value of benefit claims payable at beginning of year	2019-12-31	$0
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Aggregate proceeds on sale of assets	2019-12-31	$0
Aggregate proceeds on sale of assets	2019-12-31	$0
Aggregate carrying amount (costs) on sale of assets	2019-12-31	$0
Aggregate carrying amount (costs) on sale of assets	2019-12-31	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2019-12-31	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2019-12-31	$0
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	ALDRICH CPAS + ADVISORS LLP
Accountancy firm name	2019-12-31	ALDRICH CPAS + ADVISORS LLP
Accountancy firm EIN	2019-12-31	930623286
Accountancy firm EIN	2019-12-31	930623286
2018 : STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN 2018 401k financial data
Unrealized appreciation/depreciation of real estate assets	2018-12-31	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2018-12-31	$0
Total unrealized appreciation/depreciation of assets	2018-12-31	$0
Total transfer of assets to this plan	2018-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Expenses. Interest paid	2018-12-31	$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102	2018-12-31	$0
Total income from all sources (including contributions)	2018-12-31	$1,016,848
Total loss/gain on sale of assets	2018-12-31	$0
Total of all expenses incurred	2018-12-31	$111,921
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$80,973
Expenses. Certain deemed distributions of participant loans	2018-12-31	$0
Value of total corrective distributions	2018-12-31	$0
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$1,188,004
Value of total assets at end of year	2018-12-31	$3,620,421
Value of total assets at beginning of year	2018-12-31	$2,715,494
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$30,948
Total income from rents	2018-12-31	$0
Total interest from all sources	2018-12-31	$4,433
Total dividends received (eg from common stock, registered investment company shares)	2018-12-31	$28,529
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2018-12-31	$28,529
Administrative expenses professional fees incurred	2018-12-31	$0
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2018-12-31	Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2018-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Amount of non-exempt transactions with any party-in-interest	2018-12-31	$0
Contributions received from participants	2018-12-31	$664,326
Participant contributions at end of year	2018-12-31	$79,424
Participant contributions at beginning of year	2018-12-31	$117,054
Participant contributions at end of year	2018-12-31	$0
Participant contributions at beginning of year	2018-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$402,416
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2018-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at end of year	2018-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2018-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2018-12-31	$0
Other income not declared elsewhere	2018-12-31	$128,724
Administrative expenses (other) incurred	2018-12-31	$0
Liabilities. Value of operating payables at beginning of year	2018-12-31	$0
Total non interest bearing cash at end of year	2018-12-31	$0
Total non interest bearing cash at beginning of year	2018-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Income. Non cash contributions	2018-12-31	$0
Value of net income/loss	2018-12-31	$904,927
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$3,620,421
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$2,715,494
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Amount of loans by the plan or fixed income obligations due to the plan which were in default/classified-as-uncollectible as of the close of the plan year	2018-12-31	$0
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Amount of leases to which the plan was a party which were in default/classified-as-uncollectible during the year	2018-12-31	$0
Investment advisory and management fees	2018-12-31	$6,161
Value of interest in registered invesment companies (eg mutual funds) at end of year	2018-12-31	$546,244
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2018-12-31	$2,591,602
Value of interest in pooled separate accounts at end of year	2018-12-31	$67,016
Value of interest in pooled separate accounts at beginning of year	2018-12-31	$0
Interest on participant loans	2018-12-31	$4,433
Income. Interest from loans (other than to participants)	2018-12-31	$0
Interest earned on other investments	2018-12-31	$0
Income. Interest from US Government securities	2018-12-31	$0
Income. Interest from corporate debt instruments	2018-12-31	$0
Value of interest in common/collective trusts at end of year	2018-12-31	$2,927,737
Value of interest in common/collective trusts at beginning of year	2018-12-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2018-12-31	$0
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2018-12-31	$6,838
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2018-12-31	$6,838
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2018-12-31	$0
Expenses. Payments to insurance carriers foe the provision of benefits	2018-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2018-12-31	$802
Net investment gain/loss from pooled separate accounts	2018-12-31	$-10,934
Net investment gain or loss from common/collective trusts	2018-12-31	$-322,710
Net gain/loss from 103.12 investment entities	2018-12-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	No
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Contributions received in cash from employer	2018-12-31	$121,262
Employer contributions (assets) at end of year	2018-12-31	$0
Employer contributions (assets) at beginning of year	2018-12-31	$0
Income. Dividends from preferred stock	2018-12-31	$0
Income. Dividends from common stock	2018-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$80,973
Contract administrator fees	2018-12-31	$24,787
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2018-12-31	Yes
Liabilities. Value of benefit claims payable at beginning of year	2018-12-31	$0
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Aggregate proceeds on sale of assets	2018-12-31	$0
Aggregate carrying amount (costs) on sale of assets	2018-12-31	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2018-12-31	$0
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	ALDRICH CPAS + ADVISORS LLP
Accountancy firm EIN	2018-12-31	930623286
2017 : STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN 2017 401k financial data
Total unrealized appreciation/depreciation of assets	2017-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total income from all sources (including contributions)	2017-12-31	$800,436
Total loss/gain on sale of assets	2017-12-31	$0
Total of all expenses incurred	2017-12-31	$146,363
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2017-12-31	$116,125
Expenses. Certain deemed distributions of participant loans	2017-12-31	$0
Value of total corrective distributions	2017-12-31	$19,607
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2017-12-31	$451,945
Value of total assets at end of year	2017-12-31	$2,715,494
Value of total assets at beginning of year	2017-12-31	$2,061,421
Total of administrative expenses incurred including professional, contract, advisory and management fees	2017-12-31	$10,631
Total interest from all sources	2017-12-31	$4,541
Total dividends received (eg from common stock, registered investment company shares)	2017-12-31	$199,934
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2017-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2017-12-31	$199,934
Assets. Real estate other than employer real property at beginning of year	2017-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2017-12-31	$0
Was this plan covered by a fidelity bond	2017-12-31	No
Value of fidelity bond cover	2017-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2017-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2017-12-31	No
Contributions received from participants	2017-12-31	$393,407
Participant contributions at end of year	2017-12-31	$117,054
Participant contributions at beginning of year	2017-12-31	$103,720
Participant contributions at end of year	2017-12-31	$0
Participant contributions at beginning of year	2017-12-31	$0
Assets. Other investments not covered elsewhere at end of year	2017-12-31	$0
Assets. Other investments not covered elsewhere at beginning of year	2017-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2017-12-31	$5,290
Value of other receiveables (less allowance for doubtful accounts) at end of year	2017-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2017-12-31	$0
Assets. Loans (other than to participants) at beginning of year	2017-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2017-12-31	$0
Administrative expenses (other) incurred	2017-12-31	$450
Liabilities. Value of operating payables at beginning of year	2017-12-31	$0
Total non interest bearing cash at beginning of year	2017-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Value of net income/loss	2017-12-31	$654,073
Value of net assets at end of year (total assets less liabilities)	2017-12-31	$2,715,494
Value of net assets at beginning of year (total assets less liabilities)	2017-12-31	$2,061,421
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2017-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2017-12-31	No
Were any leases to which the plan was party in default or uncollectible	2017-12-31	No
Assets. partnership/joint venture interests at beginning of year	2017-12-31	$0
Investment advisory and management fees	2017-12-31	$3,048
Value of interest in registered invesment companies (eg mutual funds) at end of year	2017-12-31	$2,591,602
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2017-12-31	$1,955,716
Value of interest in pooled separate accounts at end of year	2017-12-31	$0
Value of interest in pooled separate accounts at beginning of year	2017-12-31	$0
Interest on participant loans	2017-12-31	$4,529
Value of interest in master investment trust accounts at end of year	2017-12-31	$0
Value of interest in master investment trust accounts at beginning of year	2017-12-31	$0
Value of interest in common/collective trusts at end of year	2017-12-31	$0
Value of interest in common/collective trusts at beginning of year	2017-12-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2017-12-31	$6,838
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2017-12-31	$1,985
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2017-12-31	$1,985
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2017-12-31	$12
Assets. Value of investments in 103.12 investment entities at end of year	2017-12-31	$0
Assets. Value of investments in 103.12 investment entities at beginning of year	2017-12-31	$0
Asset value of US Government securities at beginning of year	2017-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2017-12-31	$144,016
Net investment gain/loss from pooled separate accounts	2017-12-31	$0
Net investment gain or loss from common/collective trusts	2017-12-31	$0
Net gain/loss from 103.12 investment entities	2017-12-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2017-12-31	No
Was there a failure to transmit to the plan any participant contributions	2017-12-31	No
Has the plan failed to provide any benefit when due under the plan	2017-12-31	No
Assets. Invements in employer securities at beginning of year	2017-12-31	$0
Assets. Value of employer real property at beginning of year	2017-12-31	$0
Contributions received in cash from employer	2017-12-31	$53,248
Employer contributions (assets) at end of year	2017-12-31	$0
Employer contributions (assets) at beginning of year	2017-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2017-12-31	$116,125
Asset. Corporate debt instrument preferred debt at beginning of year	2017-12-31	$0
Asset. Corporate debt instrument debt (other) at beginning of year	2017-12-31	$0
Contract administrator fees	2017-12-31	$7,133
Assets. Corporate common stocks other than exployer securities at beginning of year	2017-12-31	$0
Liabilities. Value of benefit claims payable at beginning of year	2017-12-31	$0
Assets. Value of buildings and other operty used in plan operation at beginning of year	2017-12-31	$0
Did the plan have assets held for investment	2017-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2017-12-31	No
Liabilities. Value of acquisition indebtedness at beginning of year	2017-12-31	$0
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2017-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2017-12-31	Unqualified
Accountancy firm name	2017-12-31	ALDRICH CPAS + ADVISORS LLP
Accountancy firm EIN	2017-12-31	930623286
2012 : STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN 2012 401k financial data
Transfers to/from the plan	2012-12-31	$0
Total plan liabilities at end of year	2012-12-31	$0
Total plan liabilities at beginning of year	2012-12-31	$0
Total income from all sources	2012-12-31	$254,082
Expenses. Total of all expenses incurred	2012-12-31	$45,891
Benefits paid (including direct rollovers)	2012-12-31	$29,630
Total plan assets at end of year	2012-12-31	$839,409
Total plan assets at beginning of year	2012-12-31	$631,218
Value of fidelity bond covering the plan	2012-12-31	$0
Total contributions received or receivable from participants	2012-12-31	$169,368
Expenses. Other expenses not covered elsewhere	2012-12-31	$0
Contributions received from other sources (not participants or employers)	2012-12-31	$9,019
Other income received	2012-12-31	$75,695
Net income (gross income less expenses)	2012-12-31	$208,191
Net plan assets at end of year (total assets less liabilities)	2012-12-31	$839,409
Net plan assets at beginning of year (total assets less liabilities)	2012-12-31	$631,218
Assets. Value of participant loans	2012-12-31	$11,988
Total contributions received or receivable from employer(s)	2012-12-31	$0
Value of certain deemed distributions of participant loans	2012-12-31	$0
Value of corrective distributions	2012-12-31	$15,278
Expenses. Administrative service providers (salaries,fees and commissions)	2012-12-31	$983
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2012-12-31	$0
Funding deficiency by the employer to the plan for this plan year	2012-12-31	$0
Minimum employer required contribution for this plan year	2012-12-31	$0
Amount contributed by the employer to the plan for this plan year	2012-12-31	$0

Form 5500 Responses for STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN

2022: STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN 2022 form 5500 responses
2022-01-01	Type of plan entity	Single employer plan
2022-01-01	This submission is the final filing	No
2022-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2022-01-01	Plan is a collectively bargained plan	No
2022-01-01	Plan funding arrangement – Insurance	Yes
2022-01-01	Plan funding arrangement – Trust	Yes
2022-01-01	Plan benefit arrangement – Insurance	Yes
2022-01-01	Plan benefit arrangement - Trust	Yes
2021: STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	This submission is the final filing	No
2021-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2021-01-01	Plan is a collectively bargained plan	No
2021-01-01	Plan funding arrangement – Insurance	Yes
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement – Insurance	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	This submission is the final filing	No
2020-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2020-01-01	Plan is a collectively bargained plan	No
2020-01-01	Plan funding arrangement – Insurance	Yes
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement – Insurance	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	This submission is the final filing	No
2019-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2019-01-01	Plan is a collectively bargained plan	No
2019-01-01	Plan funding arrangement – Insurance	Yes
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement – Insurance	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	This submission is the final filing	No
2018-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2018-01-01	Plan is a collectively bargained plan	No
2018-01-01	Plan funding arrangement – Insurance	Yes
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement – Insurance	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes
2017: STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN 2017 form 5500 responses
2017-01-01	Type of plan entity	Single employer plan
2017-01-01	Submission has been amended	No
2017-01-01	This submission is the final filing	No
2017-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2017-01-01	Plan is a collectively bargained plan	No
2017-01-01	Plan funding arrangement – Trust	Yes
2017-01-01	Plan benefit arrangement - Trust	Yes
2012: STRATEGIC PHARMACEUTICAL SOLUTIONS, INC. 401(K) RETIREMENT PLAN 2012 form 5500 responses
2012-01-01	Type of plan entity	Single employer plan
2012-01-01	Submission has been amended	No
2012-01-01	This submission is the final filing	No
2012-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2012-01-01	Plan is a collectively bargained plan	No
2012-01-01	Plan funding arrangement – Trust	Yes
2012-01-01	Plan benefit arrangement - Trust	Yes

Insurance Providers Used on plan

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )

Policy contract number

466920

Policy instance

Insurance contract or identification number	466920
Number of Individuals Covered	662
Insurance policy start date	2022-01-01
Insurance policy end date	2022-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )

Policy contract number

466920

Policy instance

Insurance contract or identification number	466920
Number of Individuals Covered	542
Insurance policy start date	2021-01-01
Insurance policy end date	2021-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )

Policy contract number

466920

Policy instance

Insurance contract or identification number	466920
Number of Individuals Covered	387
Insurance policy start date	2020-01-01
Insurance policy end date	2020-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )

Policy contract number

466920

Policy instance

Insurance contract or identification number	466920
Number of Individuals Covered	340
Insurance policy start date	2019-01-01
Insurance policy end date	2019-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

PRINCIPAL LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 61271 )

Policy contract number

466920

Policy instance

Insurance contract or identification number	466920
Number of Individuals Covered	326
Insurance policy start date	2018-05-15
Insurance policy end date	2018-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	STRATEGIC PHARMACEUTICAL SOLUTIONS DBA VETSOURCE
Employer identification number (EIN):	204318957
NAIC Classification:	325410

Jurisdiction of Incorporation:	Oregon Secretary of State Corporations Division
Incorporation Date:	2005-12-05
Company Identification Number:	32659492
Legal Registered Office Address:	780 COMMERCIAL ST SE STE 100 SALEM United States of America (USA) 97301